natgillin/translations-raw huggingface dataset:
(2) or <;RCOC18~[the product does not contain and is not derived from bovine, ovine or caprine materials other than those derived from animals born, continuously reared and slaughtered in a country or region classified as posing a negligible BSE risk by a decision in accordance with Article 5(2) of Regulation (EC) No 999/2001;]~RCOC18>;
(2) ili <;RCOC18~[proizvod ne sadrži i nije dobiven od sirovina podrijetlom od goveda, ovaca ili koza, osim onih dobivenih od životinja rođenih, neprekidno uzgajanih i zaklanih u državi ili regiji kategoriziranoj u skladu s člankom 5(2) Uredbe (EZ) 999/2001 kao država ili regija s neznatnim GSE rizikom;]~RCOC18>;
(2) either <;RCOC19~[in case of animal by-products intended for feeding ruminants and containing milk or milk products of ovine or caprine origin, the ovine and caprine animals from which these products are derived have been kept continuously since birth or for the last three years on a holding where no official movement restriction is imposed due to a suspicion of TSE and which has satisfied the following requirements for the last three years:
(2) bilo <;RCOC19~[u slučaju nusproizvoda životinjskog podrijetla namijenjenih za prehranu preživača koji sadrže mlijeko ili mliječne proizvode podrijetlom od ovaca ili koza, ovce ili koze od kojih su ti proizvodi dobiveni od rođenja su ili zadnje tri godine držane na gospodarstvu kojemu nije bilo nametnuto službeno ograničenje kretanja zbog sumnje na TSE te koje je posljednje tri godine udovoljavalo sljedećim zahtjevima:
(3) OJ L 139, 30.4.2004, p. 55.
(3) SL L 139, 30.4.2004., str.
I, the undersigned official veterinarian, declare that I have read and understood Regulation (EC) No 1069/2009 of the European Parliament and of the Council(1a) and in particular Article 10 thereof, and Commission Regulation (EU) No …/2010(1b), and in particular Annex XIV, Chapter I thereof, and certify that the <;RCOC1~hydrolysed protein~RCOC1>;/<;RCOC2~dicalcium phosphate~RCOC2>;/<;RCOC3~tricalcium phosphate~RCOC3>; (2) described above:
Ja, niže potpisani službeni/ovlašteni veterinar, izjavljujem da sam pročitao i razumio Uredbu (EZ) br. 1069/2009 Europskog parlamenta i Vijeća(1a) posebno članak 10. i Uredbu Komisije (EU) br. (1b), posebno Prilog XIV., Poglavlje I. i potvrđujem da prethodno opisane <;RCOC1~hidrolizirane bjelančevine~RCOC1>;/<;RCOC2~dikalcij fosfat~RCOC2>;/<;RCOC3~trikalcij fosfat~RCOC3>; (2):
II.1. consists of <;RCOC4~hydrolysed protein~RCOC4>;/<;RCOC5~dicalcium phosphate~RCOC5>;/<;RCOC6~tricalcium phosphate~RCOC6>; (2) that satisfy the health requirements below;
II.1. sastoje se od <;RCOC4~hidroliziranih bjelančevina~RCOC4>;/<;RCOC5~dikalcij fosfata~RCOC5>;/<;RCOC6~trikalcij fosfata~RCOC6>; (2) koji udovoljavaju zdravstvenim zahtjevima navedenima u nastavku;
II.2. consists exclusively of <;RCOC61~hydrolysed protein~RCOC61>;/<;RCOC62~dicalcium phosphate~RCOC62>;/<;RCOC63~tricalcium phosphate~RCOC63>;(2) not intended for human consumption;
II.2. sastoje se isključivo od <;RCOC61~hidroliziranih bjelančevina~RCOC61>;/<;RCOC62~dikalcij fosfata~RCOC62>;/<;RCOC63~trikalcij fosfata~RCOC63>;(2) koji nisu namijenjeni prehrani ljudi;
II.3. has been prepared and stored in a plant approved, validated and supervised by the competent authority in accordance with Article 24 of Regulation (EC) No 1069/2009, in order to kill pathogenic agents;
II.3. dobiveni su i uskladišteni u objektu odobrenom, potvrđenom i nadziranom od nadležnog tijela u skladu s člankom 24. Uredbe (EZ) br. 1069/2009 radi ubijanja patogenih uzročnika;
(4) its outer packaging is labelled ‘FOR MEDICINAL PRODUCTS / VETERINARY MEDICINAL PRODUCTS / MEDICAL DEVICES/ ACTIVE IMPLANTABLE MEDICAL DEVICES / IN VITRO DIAGNOSTIC MEDICAL DEVICES/ LABORATORY REAGENTS ONLY' and it is not intended to be diverted at any stage within the Union for any other use;
(4) njegovo vanjsko pakovanje označeno je naljepnicom „SAMO ZA LIJEKOVE / VETERINARSKE LIJEKOVE / MEDICINSKE PROIZVODE / AKTIVNE USADIVE MEDICINSKE PROIZVODE / IN VITRO DIJAGNOSTIČKE MEDICINSKE PROIZVODE / LABORATORIJSKE REAGENSE“ i nisu namijenjeni za korištenje u bilo koje druge svrhe u bilo kojoj fazi unutar Unije;
(5) the consignment will be transported directly to the place of destination as indicated under point I.12 of this declaration, that is:
(5) pošiljka će biti prevezena izravno na mjesto odredišta navedeno pod točkom I.12 ove izjave, odnosno:
- an establishment or plant for the production of medicinal products, veterinary medicinal products, medical devices, in vitro diagnostics or laboratory reagents, which has been registered in accordance with Article 23 of Regulation (EC) No 1069/2009,
- u objekt za proizvodnju lijekova, veterinarskih lijekova, medicinskih proizvoda, in vitro dijagnostičkih proizvoda ili laboratorijskih reagensa koji je registriran u skladu s člankom 23. Uredbe (EZ) br.
- an establishment or plant which has been approved in accordance with Article 24(1)(i) of Regulation (EC) No 1069/2009, from where they shall only be dispatched to an establishment or plant referred to in the preceding subpoint of (5).
- u objekt koji je odobren u skladu s člankom 24(1)(i) Uredbe (EZ) br. 1069/2009, iz kojeg se otpremaju samo u objekt naveden u prethodnoj podtočki (5).
(iv) dead-in-shell poultry;]~RCOC20>;
(iv) mrtva perad koja se nije izlegla;]~RCOC20>;
(2) and/or <;RCOC21~[- animal by-products other than Category 1 material or Category 3 material;]~RCOC21>;
(2) i/ili <;RCOC21~[- nusproizvodi životinjskog podrijetla osim materijala kategorije 1 ili materijala kategorije 3;]~RCOC21>;
(iii) oocytes, embryos and semen which are not destined for breeding purposes; and
(iii) jajajšca, embriji i sjeme koji nisu namijenjeni za uzgajanje; i
specify if hydrolysed protein, dicalcium phosphate or tricalcium phosphate.
navesti radi li se o hidroliziranim bjelančevinama, dikalcij fosfatu ili trikalcij fosfatu.
II.1. come from a plant for the manufacture of products for purposes other than feeding to farmed animals, a biogas plant or a composting plant approved by the competent authority of the third country meeting the special conditions laid down in Regulation (EC) No 1069/2009 and in Regulation (EU) No …/2010;
II.1. potječu iz objekta za proizvodnju proizvoda u svrhe osim hranjenja uzgajanih životinja, objekta koji proizvodi bioplin ili kompost, a koji je odobrilo nadležno tijelo treće zemlje koje ispunjava posebne zahtjeve navedene u Uredbi (EZ) br. 1069/2009 i Uredbi (EU) br.
II.2(2) have been subjected to:
II.2(2) podvrgnuti su:
<;RCOC1~[a heat treatment process of at least 70 °C for at least 60 minutes;]~RCOC1>; or
<;RCOC1~[toplinskoj obradi na najmanje 70 °C najmanje 60 minuta;]~RCOC1>; ili
<;RCOC2~[an equivalent treatment validated and authorised by the importing Member State in accordance with the specific conditions laid down in Regulation (EC) No 1069/2009 and in Regulation (EU) No …/2010 as follows:
<;RCOC2~[ekvivalentnoj obradi koju je potvrdila i odobrila država članica uvoznica u skladu sa specifičnim uvjetima navedenima u Uredbi (EZ) br. 1069/2009 te u Uredbi (EU) br. …/2010 kako slijedi:
II.3. are:
II.3. su:
(a) free from Salmonella (no salmonella in 25 g treated product);
(a) slobodni od Salmonelle (bez salmonele u 25 g obrađenog proizvoda);
(b) free from Escherichia coli or from Enterobacteriaceae (based on the aerobic count:
(b) slobodni od Escherichie coli ili Enterobacteriaceae (temeljem broja aerobnih bakterija:
II.3. have been prepared and stored in a plant approved, validated and supervised by the competent authority in accordance with Article 24 of Regulation (EC) No 1069/2009, in order to kill pathogenic agents;
II.3. dobiveni su i uskladišteni u objektu odobrenom, potvrđenom i nadziranom od nadležnog tijela u skladu s člankom 24. Uredbe (EZ) br. 1069/2009 radi ubijanja patogenih uzročnika;
II.4. have been prepared from rendered fats exclusively produced from the following Category 3 materials:
II.4. dobiveni su od prerađenih masti proizvedenih isključivo od sljedećih materijala kategorije 3:
II.1. consist of fat derivatives that satisfy the health requirements below;
II.1. sastoje se od derivata masti koji udovoljavaju zdravstvenim zahtjevima navedenima u nastavku;
II.2. consist of fat derivatives not intended for human consumption;
II.2. sastoje se isključivo od derivata masti koji nisu namijenjeni prehrani ljudi;
(i) treatment with acid for at least two days, washing with water and treatment with an alkaline solution for at least 20 days; the pH must be adjusted and the material purified by means of filtration and sterilised at 138-140 ˚C for 4 seconds; or
(i) obradi kiselinom najmanje dva dana, ispiranju vodom i obradi lužnatom otopinom najmanje 20 dana; pH mora biti prilagođen i materijal pročišćen filtracijom te steriliziran pri 138-140 ˚C 4 sekunde; ili
(ii) treatment with alkali for at least two days, washing with water and treatment with an acid solution for 10-12 hours; the pH must be adjusted and the material purified by means of filtration and sterilised at 138-140 ˚C for 4 seconds.
(ii) obradi lužinom najmanje dva dana, ispiranju vodom i obradi kiselom otopinom 10-12 sati; pH mora biti prilagođen i materijal pročišćen filtracijom te steriliziran pri 138-140 ˚C 4 sekunde.
II.6. has been wrapped and packaged in wrappings and packages carrying the words “PHOTOGRAPHIC GELATINE FOR THE PHOTOGRAPHIC INDUSTRY ONLY”.
II.6. umotana je i zapakirana u omote i pakete s nazivom „FOTOGRAFSKA ŽELATINA SAMO ZA FOTOGRAFSKU INDUSTRIJU“.
● Box reference I.5:
● Rubrika I.5:
The intended destination of the photographic gelatine can only be the Czech Republic, the Netherlands or the United Kingdom.
Planirano odredište fotografske želatine može biti samo Češka, Nizozemska ili Ujedinjena Kraljevina.
● Box reference I.9:
● Rubrika I.9:
Country of destination:
Država odredišta:
only applicable for the Czech Republic, the Netherlands or the United Kingdom.
primjenjivo samo za Češku, Nizozemsku ili Ujedinjenu Kraljevinu.
● Note for the person responsible for the load in the European Union:
● Napomena za odgovornu osobu za pošiljku u Europskoj uniji:
this certificate is only for veterinary purposes and has to accompany the consignment until it reaches the factory of destination from the border inspection post.
ovaj certifikat služi isključivo u veterinarske svrhe i mora pratiti pošiljku sve dok ne stigne iz granične veterinarske postaje u odredišnu tvornicu.
Intermediate products to be used for the manufacture of medicinal products, veterinary medicinal products, medical devices, in vitro diagnostics and laboratory reagents
Poluproizvodi namijenjeni korištenju za proizvodnju lijekova, veterinarskih lijekova, medicinskih proizvoda, in vitro dijagnostičkih proizvoda i laboratorijskih reagensa
DECLARATION
IZJAVA
I, the undersigned, declare that the intermediate product referred to above is intended to be imported by me into the Union and satisfy the definition provided for in point 35 of Annex I of Commission Regulation (EU) No …/2010(1a), and in particular that:
Ja, niže potpisani, izjavljujem da je prethodno navedeni poluproizvod namijenjen za uvoz od strane mene u Uniju te da udovoljava definiciji navedenoj u točki 35. Priloga I. Uredbe Komisije (EU) br. (1a), a posebno da:
(1) it is intended for the manufacture of:
(1) je namijenjen proizvodnji:
(2) either <;RCOC1~[- medicinal products,]~RCOC1>;
(2) bilo <;RCOC1~[- lijekova,]~RCOC1>;
(2) and/or <;RCOC2~[- veterinary medicinal products,]~RCOC2>;
(2) i/ili <;RCOC2~[- veterinarskih lijekova,]~RCOC2>;
(2) and/or <;RCOC3~[- medical devices,]~RCOC3>;
(2) i/ili <;RCOC3~[- medicinskih proizvoda,]~RCOC3>;
(2) and/or <;RCOC4~[- active implantable medical devices,]~RCOC4>;
(2) i/ili <;RCOC4~[- aktivnih usadivih medicinskih proizvoda,]~RCOC4>;
(2) and/or <;RCOC5~[- in vitro diagnostic medical devices,]~RCOC5>;
(2) i/ili <;RCOC5~[- in vitro dijagnostičkih medicinskih proizvoda,]~RCOC5>;
(2) and/or <;RCOC6~[- laboratory reagents;]~RCOC6>;
(2) i/ili <;RCOC6~[- laboratorijskih reagensa;]~RCOC6>;
(2) its design, transformation and manufacturing stages have been sufficiently completed in order to qualify the material directly or as a component of a product intended for that purpose, except for the fact that it requires further handling or transformation such as mixing, coating, assembling, packaging or labelling to make it suitable for placing on the market or putting into service as medicinal products, veterinary medicinal products, active implantable medical device, medical devices or in vitro diagnostic medical device in accordance with the Union legislation(1b) applicable to those products or as laboratory reagents;
(2) njegovi stadiji dizajna, transformacije i proizvodnje uspješno su dovršeni radi izravnog osposobljavanja materijala ili osposobljavanja materijala kao dijela proizvoda namijenjenog u tu svrhu, osim kada zahtijeva dodatnu doradu ili transformaciju kao što je miješanje, oblaganje, sastavljanje, pakiranje ili označavanje kako bi bio prikladan za plasiranje na tržište ili stavljanje u službu kao lijek, veterinarski lijek, aktivni usadivi medicinski proizvod, medicinski proizvodi ili in vitro dijagnostički medicinski proizvod u skladu sa zakonodavstvom Unije(1b) koje se odnosi na te proizvode ili laboratorijske reagense;
(3) it has been derived from the following material which may have originated from animals which have been submitted to illegal treatment as defined in Article 1(2)(d) of Council Directive 96/22/EC or Article 2(b) of Council Directive 96/23/EC(2):
(3) dobiven je od sljedećih materijala koji mogu potjecati od životinja koje su bile podvrgnute protuzakonitom tretiranju kako je definirano člankom 1(2)(d) Direktive Vijeća 96/22/EZ ili člankom 2(b) Direktive Vijeća 96/23/EZ(2):
(1a) OJ L …, …
(1a) SL L …, …
(1b) Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products (OJ L 311, 28.11.2001), Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p.67), Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (OJ L 169, 12.7.1993, p.1.) and Directive 98/79/EC of the European Parliament and the Council of 27 October 1998 on in vitro diagnostic medical devices (OJ L 331, 7.12.1998, p.1.), as appropriate.
(1b) Direktiva 2001/82/EZ Europskog parlamenta i Vijeća od 6. studenog 2001. o zakonu Zajednice koji se odnosi na veterinarske lijekove (SL L 311, 28.11.2001.), Direktiva 2001/83/EZ Europskog parlamenta i Vijeća od 6. studenog 2001. o zakonu Zajednice koji se odnosi na lijekove za ljudsku uporabu (SL L 311, 28.11.2001, str. 67), Direktiva Vijeća 93/42/EEZ od 14. lipnja 1993. koja se odnosi na medicinske proizvode (SL L 169, 12.7.1993, str. i Direktiva 98/79/EZ Europskog parlamenta i Vijeća od 27. listopada 1998. o in vitro dijagnostičkim medicinskim proizvodima (SL L 331, 7.12.1998., str. 1.), prema potrebi.
II.1.1 come from holdings which have been free from any official prohibition on health grounds, for the last 42 days in the case of brucellosis, for the last 30 days in the case of anthrax and for the past six months in the case of rabies and, the animals have not been in contact with animals from holdings which did not satisfy these conditions;
II.1.1. dolaze iz gospodarstava u kojima nije bilo službenih zabrana zbog zdravstvenih razloga, u prethodna 42 dana u slučaju bruceloze, u prethodnih 30 dana u slučaju bedrenice i u posljednjih 6 mjeseci u slučaju bjesnoće te da životinje nisu bile u kontaktu sa životinjama iz gospodarstava koja ne udovoljavaju navedenim uvjetima;
II.1.2 have not received:
II.1.2 nisu tretirane:
- any stilbene or thyrostatic substances,
- stilbenima ili tireostaticima,
(2) or <;RCOC2~[(a) (i) has been free <;CCOC101~[for 24 months from foot-and-mouth disease]~CCOC101>;(2), for 12 months from rinderpest, African swine fever, vesicular exanthema, <;CCOC102~[classical swine fever]~CCOC102>;(2) and <;CCOC103~[swine vesicular disease]~CCOC103>;(2), and for 6 months from vesicular stomatitis, and
(2) ili <;RCOC2~[(a) (i) <;CCOC101~[posljednja 24 mjeseca bio slobodan od slinavke i šapa]~CCOC101>;(2), a posljednjih 12 mjeseci od goveđe kuge, afričke svinjske kuge, vezikularnog egzantema <;CCOC102~[klasične svinjske kuge]~CCOC103>;(2) i <;CCOC103~[vezikularne bolesti svinja]~CCOC1003>;(2) te posljednjih šest mjeseci od vezikularnog stomatitisa i
(ii) has been considered free from <;CCOC104~[foot-and-mouth disease]~CCOC104>;(2), <;CCOC105~[classical swine fever]~CCOC105>;(2) and <;CCOC106~[swine vesicular disease]~CCOC106>;(2), since <;AB2>; (dd/mm/yyyy), without having had cases/outbreaks from that date, and authorised to export these animals by Commission Decision <;AB3>;/<;AB4>;/EU, of <;AB5>; (dd/mm/yyyy) , and]~RCOC2>;
(ii) se smatra slobodnim od <;CCOC104~[slinavke i šapa]~CCOC104>;(2), <;CCOC105~[klasične svinjske kuge]~CCOC105>;(2) i <;CCOC106~[vezikularne bolesti svinja]~CCOC1006>;(2) , od<;AB2>; (dd/mm/gggg), bez kasnijih slučajeva/izbijanja bolesti i odlikom Europske komisije odobreno je za izvoz ovih životinja <;AB3>;/<;AB4>; od <;AB5>; (dd/mm/gggg), i]~RCOC2>;
(b) where during the last 12 months, no vaccination against these diseases has been carried out and imports of domestic cloven-hoofed animals vaccinated against these diseases are not permitted.
(b) teritorij na kojem se u posljednjih 12 mjeseci nije provodilo cijepljenje protiv ovih bolesti i nije dopušten uvoz domaćih papkara cijepljenih protiv ovih bolesti;
- oestrogenic, androgenic, gestagenic or b- agonist substances for purposes other than therapeutic or zootechnic treatment (as defined in Directive 96/22/EC).
- estrogenim, androgenim, gestagenim tvarima ili β-agonistima osim u terapeutske ili zootehničke svrhe (kako je određeno Direktivom Vijeća 96/22/EZ).
II.2. Animal Health attestation
II.2. Potvrda o zdravlju životinja
914/2011 (605/2010) Dairy products derived from milk of cows, ewes, goats and buffaloes for human consumption from third countries authorised in column B
914/2011 (605/2010) Mliječni proizvodi dobiveni od mlijeka krava, ovaca, koza i bivolica za prehranu ljudi iz trećih zemalja ili njihovih dijelova koji su odobreni u stupcu B
Animal Health Attestation
Potvrda o zdravlju životinja
I, the undersigned official veterinarian, declare that I am aware of the relevant provisions of Directive 2002/99/EC and of Regulation (EC) No 853/2004 and hereby certify that the dairy product described above:
Ja, niže potpisani službeni/ovlašteni veterinar, potvrđujem da sam upoznat s odgovarajućim odredbama Direktive 2002/99/EZ i Uredbe (EZ) 853/2004 i ovim potvrđujem da je gore opisani mliječni proizvod:
(a) has been obtained from animals:
(a) dobiven od životinja:
(ii) which were in a country or part thereof that has been free of foot-and-mouth disease and of rinderpest for a period of at least 12 months prior to the date of this certificate, and where vaccination against foot-and-mouth disease has not been carried out during that period,
(ii) koje su boravile u državi ili njezinom dijelu koji je bio slobodan od slinavke i šapa i goveđe kuge u razdoblju od najmanje 12 mjeseci prije datuma izdavanja ovoga certifikata i u kojem se tijekom tog razdoblja nije provodilo cijepljenje protiv slinavke i šapa,
(iii) belonging to holdings which were not under restrictions due to foot-and-mouth disease or rinderpest, and,
(iii) koje dolaze s gospodarstava koja nisu bila pod zabranama zbog slinavke i šapa ili goveđe kuge, i
(iv) subject to regular veterinary inspections to ensure that they satisfy the animal health conditions laid down in Chapter I of Section IX of Annex III to Regulation (EC) No 853/2004 and in Directive 2002/99/EC,
(iv) koje su podvrgnute redovitim veterinarskim pregledima kako bi se osiguralo da udovoljavaju uvjetima zdravlja životinja kako je propisano u Poglavlju I. Dijela IX. Priloga III. Uredbe (EZ) br. 853/2004 i u Direktivi 2002/99/EZ,
(b) has undergone or been produced from raw milk which has been submitted to a pasteurisation treatment involving a single heat treatment with a heating effect at least equivalent to that achieved by a pasteurisation process of at least 72°C for 15 seconds and where applicable, sufficient to ensure a negative reaction to an alkaline phosphatase test applied immediately after the heat treatment.
(b) podvrgnut ili je proizveden od sirovog mlijeka koje je podvrgnuto postupku pasterizacije jednokratnom toplinskom obradom koja je barem jednakovrijedna učinku postignutom procesom pasterizacije od najmanje 72 °C kroz 15 sekundi te koja je također dovoljna da osigura negativnu reakciju na test alkalne fosfataze primijenjen neposredno nakon toplinske obrade.
II.1. I am aware of the relevant provisions of Regulations (EC) 178/2002, (EC) No 852/2004 and (EC) No 853/2004, in particular Article 6.1(b) on the origin of the products of animal origin used in the production of the composite products described above and certify that the composite products described above were produced in accordance with those requirements, in particular that they come from (an) establishment(s) implementing a programme based on the HACCP principles in accordance with Regulation (EC) No 852/2004;
II.1. da sam upoznat s važećim odredbama Uredbi (EZ) br.178/2002, (EZ) br.852/2004 i (EZ) 853/2004, osobito člankom 6.1(b) o podrijetlu proizvoda životinjskog podrijetla koji se kiliiste u proizvodnji mješovitih proizvoda, gilie opisanih, i potvrđujem da su gilie opisani mješoviti proizvodi proizvedeni u skladu s tim zahtjevima, posebice da dolaze iz objek(a)ta koji primjenjuju program temeljen na načelima HACCP-a u skladu s Uredbom (EZ) br.852/2004;
II.2. the composite products described above contain:
II.2. gilie opisani mješoviti proizvodi sadrže:
(1)either <;CCOC1~[II.2.A Meat products, treated stomachs, bladders and intestines(2) in any quantity which meet the animal health requirements in Commission Decision 2007/777/EC and contain the following meat constituents which meet the criteria indicated below:
(1)bilo <;CCOC1~[II.2.A Proizvode od mesa, obrađene želuce, mjehure i crijeva(2 u bilo kojoj količini, koji ispunjavaju zahtjeve za zdravlje životinja iz Odluke Komisije 2007/777/EZ i sadrže slijedeće sastojke mesa koji zadovoljavaju uvjete navedene u nastavku:
Species (A) Treatment (B) Origin (C) Approved Establishment(s) (D)
Vrsta (A) Obrada (B) Izvor (C) Odobreni objekt(i) (D)
(B) Insert A, B, C, D, E or F for the required treatment as specified and defined in Parts 2, 3 and 4 of Annex II to Decision 2007/777/EC.
(B) Umetnuti A, B, C, D, E ili F za zahtjevanu obradu kako je navedeno i određeno u Dijelu 2., 3. i 4. Priloga II. Odluke Komisije 2007/777/EZ.
(C) Insert the ISO code of the country of origin of the meat product, treated stomachs, bladders and intestines as listed in Annex II, Part 2 to Decision 2007/777/EC and, in the case of regionalization by Union legislation for the relevant meat constituents, the region as indicated in Part 1 of Annex II to Decision 2007/777/EC or a Member State of the European Union.
(C) Umetnuti ISO kod države podrijetla proizvoda od mesa, obrađenih želudaca, mjehura i crijeva kako je navedeno u Prilogu II. Dijelu 2. Odluke 2007/111/EZ i, u slučaju regionalizacije prema zakonodavstvu Unije za odgovarajuće mesne sastojke, regije kako je navedeno u Prilogu II. Dijelu 1. Odluke 2007/777/EZ.
The country of origin of the meat products must be one the following:
Zemlja podrijetla proizvoda od mesa mora biti jedna od sljedećih:
- the same as the country of export in box 1.7;
- ista kao država izvoznica u rubrici 1.7;
- a Member State of the European Union;
- država članica Europske unije;
- a third country or parts thereof authorised to export to the Union meat products treated with treatment A as set out in Annex II to Decision 2007/777/EC, where the third country where the composite product is produced is also authorised to export to the Union meat products treated with that treatment.
- treća zemlja ili njezin dio ovlašten za izvoz mesnih proizvoda s obradom A kako je navedeno u Prilogu II. Odluke 2007/777/EZ, pri čemu je treća zemlja u kojoj se mješoviti proizvod proizvodi ovlaštena za izvoz proizvoda od mesa obrađenih tom obradom u Uniju.